Background/Aims: Sodium iodate (NaIO 3 )-induced acute retinal injury is typically used as an animal model for degenerative retinal disease; however, how NaIO 3 influences the apoptosis, proliferation and differentiation of endogenous retinal stem cells is unknown. Methods: We exposed a radial glial cells (RGCs) line (L2.3) to different NaIO 3 concentrations and determined the influence of NaIO 3 on apoptosis, proliferation, and differentiation using flow cytometry and immunofluorescence assays. We used a real-time polymerase chain reaction assay to analyze the levels of mRNAs encoding GSK-3β, AXIN2, β-catenin, TGF-β1, SMAD2, SMAD3, NOG (Noggin), and BMP4. Results: Cell density decreased dramatically as a function of the NaIO 3 dose. NaIO 3 increased apoptosis, inhibited mitosis, proliferation, and the Wnt/β-catenin pathway. CHIR99021 (Wnt agonist) treatment efficiently reversed the effects of NaIO 3 on the apoptosis and proliferation of RGCs. The number of neuronal class III β-tubulin-positive cells decreased markedly, whereas that of glial fibrillary acidic protein-positive cells increased significantly when RGCs were exposed to NaIO 3 . During differentiation, the Nog mRNA level decreased and transforming growth factor-β1 (Tgf-β1) and Smad2/3 mRNA levels increased significantly when RGCs were exposed to NaIO 3 . Conclusion: NaIO 3 increased apoptosis, influenced the proliferation of RGCs and drove them toward astrocytic differentiation, likely through inhibition of the Wnt/β-catenin and noggin pathways and activation of the TGF-β1/ SMAD2/3 pathway.
Introduction
Age-related macular degeneration (AMD) is the main cause of blindness in developed countries [1] . Similar to retinal dystrophies, Stargardt disease, and some forms of retinitis pigmentosa, AMD is considered a disease of the retinal pigment epithelium (RPE) [2] . Sodium iodate (NaIO 3 )-induced loss or degeneration of the RPE serves as a frequently used model of acute retinal injury. In this system, NaIO 3 selectively damages the RPE, causing dysfunction of photoreceptors or injuring intraretinal neurons at an early development stage [3] .
The retina, a component of the central nervous system (CNS), possesses the potential to self-repair through the activation of endogenous stem cells. Glial cells exhibit stem-celllike properties and generate neurons, glia, or both. The major glial cell type in the retina is Müller glial cells [4] . Compared with the efficiency seen in lower vertebrates, including fish and amphibians, the efficiency of Müller glial cell regeneration is extremely low in mammals, although Müller glial cells represent the primary source of new neurons in mammals [5] . Das et al. isolated Müller glial cells from rats on postnatal (PN) days 10-21 and treated them with FGF2. A subset of these Müller glial cells proliferated to generate neurospheres that displayed characteristic features of neural stem cells (NSCs), including uptake of 5-ethynyl-20-deoxyuridine (BrdU) and expression of Sox2, nestin, and Musashi [6] . Further, Müller glial cells that re-enter the cell cycle express the markers of bipolar and photoreceptor cells [7, 8] . Müller glial cells remain dormant in the adult retina; however, when injured by a neurotoxin and transplanted into the retina, they migrate into all layers of the retina and express the markers of rod photoreceptor, amacrine, and ganglion cells [6] . Taken together, these findings suggest that Müller glial cells may represent mammalian retinal stem cells. Moreover, mature Müller glial cells share several markers with RGCs, including glial fibrillary acidic protein (GFAP) and vimentin [9] [10] [11] , and the immature Müller glia of zebrafish also express the RGC marker brain lipid binding protein (BLBP) [12] .
Müller glial cells are the only glial cells that are derived from the retinal neuroepithelium in the mammalian retina. After injury, astrocyte activation in the brain usually causes glial scar formation, which is referred to as reactive gliosis. Pathological conditions usually activate Müller glial cells [13] . Kiuchi et al. reported that Müller glial cells proliferated on the third day after mice were administered NaIO 3 ; moreover, the ratio of GFAP-positive cells increased markedly for 28 days [14] . Reactive gliosis, which may cause formation of a harmful scar, is thought to have detrimental effects on retinal neurons; however, reactive gliosis provides neuroprotection and participates in tissue repair [15] . Müller glial cells promote tissue repair by phagocytosing the products of neuronal degeneration, such as exogenous particles, cell debris, and hemorrhagic products, particularly those derived from dying photoreceptors [16] .
Further, Müller glial cells protect against the excitotoxic effects of excessive stimulation by glutamate by mediating the amidation of glutamate to generate a non-neuroactive compound [17] . These cells protect against reactive oxygen species by synthesizing glutathione that is transferred to neurons [18] . They also secrete neurotrophic factors, including vascular endothelial growth factor (VEGF) [19] . However, overexpression of VEGF may lead to retinal vasculature proliferation that may cause retinal neurodegeneration [20] . There is controversy regarding whether gliosis impedes the recovery of vision after an injury, protects against the formation of a secondary lesion [13] , or both.
Thus, the mechanisms that precisely orchestrate the proliferation and differentiation of Müller glial cells remain largely unknown. Therefore, the goal of this study was to define these mechanisms. Radial glia are found in regions of the cortex, cerebellum, spinal cord, and retina, and constitute the major cortex stem cell population in the developing brain [21] . RGCs originate from the neuroepithelium and populate the adult CNS as Müller glial cells in the retina and as Bergmann glia in the cerebellum [22] . Radial glia are NSCs that initially generate neurons and later differentiate into astrocytes during CNS development [23] . Therefore, because of their common origin, we consider RGCs as a valid experimental substitute for Müller glial cells.
The Wnt/β-catenin pathway plays a central role in self-renewal and apoptosis [24, 25] . Ablation of the expression of β-catenin [26] or low density lipoprotein receptor-related protein 6 (LRP6) [27] (essential coreceptor in the Wnt/β-catenin pathway, whose ligand is recognized as Dickkopf-1 [28] ) markedly impairs neural system development. Neural stem cell differentiation is modulated by Noggin and bone morphogenetic protein 4 (BMP4). BMP4 directs the radial glia-like cells to differentiate into astroglia; however, Noggin induces the differentiation of radial glia-like cells into neurons through antagonizing BMP4 activity [29] . In contrast, transforming growth factor-β1 (TGF-β1) acts as an injury-related cytokine associated with astrocyte scar formation in response to brain injury [30] . TGF-β1 activates SMAD2/3 transcription factors, which then form a complex with SMAD4 that activates the transcription of target genes [31] . The output of this signaling pathway promotes the differentiation of radial glia-like cells into astrocytes in vitro [32] . Therefore, we investigated the effects of these signaling pathways on the proliferation and differentiation potential of RGCs after NaIO 3 treatment in vitro.
In the present study, we established a model system to study NaIO 3 -induced injury to endogenous retinal stem cells (RSCs) in an attempt to determine the mechanisms underlying the proliferation and differentiation of RGCs.
Materials and Methods

Culture and differentiation of L2.3 cells
The L2.3 cells used were a gift from H. Li [33] . Cells were dissected from the forebrains of E14.5 rat embryos without meningeal membranes, which contain a large number of radial glia. The colonies expressed radial glial-markers, that is, brain lipid binding protein 7 (FABP7; also called BLBP), nestin, and vimentin, but not the markers of neurons (β-III tubulin) and oligodendrocytes (O4). L2.3 cells differentiate to neurons and glia (astrocytes and oligodendrocytes), express the same markers, and exhibit the same differentiation potential as RGCs and NSCs [33, 34] .
L2.3 cells were grown as floating neurospheres in DMEM/F12 (Invitrogen, USA) supplemented with 25 mM glucose (Sigma-Aldrich, USA), 10 ng/ml basic fibroblast growth factor (BD Bioscience, USA), 50 × B27 (Gibco, USA), 2 μg/ml heparin (Sigma-Aldrich) and 100 U/ml penicillin and streptomycin (Gibco) at 37°C in a humidified atmosphere containing 5% CO 2 . The cultures were passaged without replenishing the culture medium when the neurospheres grew into aggregates of 50-100 cells (usually in 2-3 days). During passaging, the neurospheres and culture medium were transferred into sterilized Eppendorf microfuge tubes and were dissociated into single cells by pipetting them repeatedly in the pipet tip. After centrifuging the solution (150 ×g/5 min) and removing the supernatant, the cells were resuspended in an appropriate volume of fresh culture medium.
To induce differentiation, the cells were cultured on polylysine-and laminin-coated coverslips in 50× B27 containing serum-free medium (DMEM/F12 with 25 mM glucose and 100 U/ml penicillin and streptomycin) for 7 days. To minimize the influence of exogenous factors, we did not add fetal bovine serum to the medium. These culture conditions and differentiation protocols were modifications of those described by Li et al. [33, 35] . The final concentrations of NaIO 3 (Sigma-Aldrich) added to the culture and differentiation medium were 0.5 μg/ml, 5 μg/ml, and 50 μg/ml. For the differentiation potential assay, the cells were collected at 7 days after differentiation.
Cell proliferation assay
After the cells were exposed to NaIO 3 , the number of cells in each of the three wells was determined. The data represent the mean of three independent experiments. The proliferative potential of L2.3 cells was measured on days 1-3 after NaIO 3 treatment. Neurospheres were labeled with 10 μM BrdU for 2 h, dissociated into single cells, and cultured on coverslips coated with polylysine and laminin. After attachment for 6 h, the cells were fixed with 4% paraformaldehyde for 30 min at 4°C, incubated in 2N HCl for 30 min at 37°C and processed for BrdU immunostaining after washing with 0.1 M borate buffer for 10 min.
To determine the role of Wnt signaling in the proliferation of RGCs, the Wnt agonist CHIR99021 (3μM; R&D, USA) was added to culture media containing different concentrations of NaIO 3 on day 1.
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Fluorescence-activated cell sorting (FACS) analysis of apoptosis, the cell cycle, and differentiation
Neurospheres were dissociated, centrifuged as described above, cooled, and washed twice with phosphate-buffered saline (PBS). All procedures were performed in an ice bath to minimize cell death induced by mechanical injury. The cells were stained with propidium iodide (PI) and Annexin V conjugated to fluorescein isothiocyanate (FITC) for 15 min at room temperature and were shielded from light. The cell distribution was determined using a FACSCalibur Flow Cytometer (BD Bioscience) and analyzed using the Flowjo software (TreeStar, USA). At least 10,000 cells were analyzed per sample. The experiments were performed in triplicate, and each result represents the mean of three independent experiments.
The cell-harvesting procedure described above yielded consistent results. The cells were fixed after cooling in 70% ethanol solution for 12 h and were then stained using the Cycletest™ Plus DNA Reagent Kit (BD Bioscience). DNA content was determined using a FACSCalibur Flow Cytometer, and the data were analyzed using the ModFit 2.0 software (BD Bioscience). At least 20,000 cells in each sample were analyzed.
To determine the number of cells undergoing differentiation, the cells were trypsinized and collected 7 days after treatment. The cells were fixed in 70% ethanol solution for 30 min, permeabilized with 0.1% Triton X-100 (Amresco, USA) for 10 min, and blocked with 3% bovine serum albumin (BSA, Sigma-Aldrich) and 10% normal goat serum (Boster, China) for 1 h. The cells were washed three times between procedures. The cells were then incubated with either anti-neuronal class III β-tubulin (Tuj1) or anti-glial fibrillary acidic protein (GFAP) antibody (BD Bioscience) for 30 min at 4°C and shielded from light. After washing with PBS, the cell numbers were determined using a FACSCalibur Flow Cytometer, and the data were analyzed using the Flowjo software. At least 10,000 cells were analyzed in each sample. Negative control experiments were performed in parallel using antibodies against unrelated proteins (Mouse IgG2a κ Isotype Control for Tju1 and Mouse IgG2b κ Isotype Control for GFAP; BD Bioscience). All FACS analyses were performed in triplicate, and each result represents the mean of three independent experiments.
Immunocytochemistry and cell counting
For immunostaining, cells were fixed with 4% paraformaldehyde for 30 min at 4°C, permeabilized with 0.1% Triton X-100 for 10 min, and blocked with 3% BSA and 10% normal goat serum for 1 h at room temperature. The cells were incubated with primary antibodies overnight at 4°C, followed by incubation with secondary antibodies for 1 h at 37°C. Nuclei were stained with 4′, 6-diamidino-2-phenylindole (DAPI, Beyotime, China). The cells were washed three times with PBS between procedures. Primary antibodies and their dilutions were as follows: mouse anti-BrdU (1:200, Abcam, UK), rabbit anti-BrdU (1:200, Bioss, China), rabbit anti-active Caspase-3 (1:150, Abcam, UK), mouse anti-Tuj1 (1:400; Beyotime), and rabbit anti-GFAP (1:200; Abcam, UK). Secondary antibodies were conjugated to Alexa Fluor ® 488 (goat anti-mouse IgG, 1:400; Beyotime) or Cy3 (goat anti-mouse IgG, 1:500, Beyotime; goat anti-rabbit IgG, 1:500, Beyotime). Negative control experiments were performed in parallel using normal goat serum instead of the primary antibodies.
The apoptosis of L2.3 RGCs treated with NaIO3 was analyzed by Terminal Deoxy Nucleotidyl Transferase-Mediated Nick End Labeling (TUNEL) assay using an In Situ Cell Death Detection Kit (Roche, Indianapolis, IN). According to the manufacturer' instructions, cells were fixed, permeabilized and incubated with the mixture of enzyme solution (TdT) and Label Solution (fluorescein-dUTP; 1:9) for 1 h at 37ºC. The nuclei of the cells were stained with DAPI (Beyotime, China). The cells were washed three times with PBS between procedures.
After immunostaining, the cells were observed and analyzed using a fluorescence microscopy system (Leica, Germany). At least 10 fields were counted for each slide. The number of cells in each field was measured by counting DAPI-positive nuclei. The expression level of each antigen was determined by calculating the ratio of positive cells to the total number of cells. All operations were performed in triplicate, and each result represents the mean of three independent experiments.
Real-time polymerase chain reaction (PCR)
We analyzed the expression of genes encoding signal transduction proteins by using quantitative (realtime) reverse transcription PCR. The primers used fulfilled all the requirements for real-time PCR primers and were therefore very specific (Table 1) . Total RNA was purified using TRIzol reagent (Invitrogen) and quantified using spectrophotometry. After reverse transcription performed using the ReverTra Ace ® qPCR RT Kit (Toyobo, Japan), real-time PCR reactions were performed using an ABI PRISM 7900HT System (Applied Biosystems, USA) using the Realtime PCR Master Mix TM (Toyobo). The volumes used for the PCR
Results
Effect of NaIO3 on the morphological features, survival, and proliferation of RGCs
In preliminary experiments, we treated L2.3 cells with different concentrations of NaIO 3 as follows: low (0.5 μg/ml), medium (5 μg/ml), and high (50 μg/ml) doses. Observations of the cells using phase-contrast microscopy did not detect obvious morphological changes at any concentration. Two days after NaIO 3 treatment, the density of cells treated with the highest dose peaked and then decreased. Cells treated with low-and medium-doses grew to a higher density that peaked on day 3 and then decreased dramatically. There was no significant difference between the growth of the control and low-dose-treated cells (Fig. 1) .
Apoptosis increased as a function of increase in NaIO 3 concentration, and more than 50% of the cells were apoptotic at the highest concentration. The difference between the control and cells treated with the lowest dose was not significant, consistent with the results of the cell proliferation assay (Fig. 2) . The ratio of Caspase-3 positive cells was significantly higher when treated with medium and high doses of NaIO 3 for 1 and 3 days, while low doses of NaIO 3 did not changed the ratio of Caspase-3 positive cells (Fig. 3) . And the ratio of TUNEL-positive cells was increased in a dose depended manner when treated with NaIO 3 in 1 to 3 days (Fig. 4) .
The mitotic ratio was highest for all NaIO 3 concentrations after day 1 and then decreased. The ratio was lowest on day 2 and rose on day 3. These results were similar to those of The number of cells in each well was determined at the indicated times. A-D Morphologic differences on day 3 among controls and cells treated with low (0.5 μg/ml), medium (5 μg/ml), or high doses (50 μg/ml) of NaIO 3 . E, F Growth rates of L2.3 cells in the presence or absence of NaIO 3 . Data from at least three independent experiments are represented as the mean ± (SD). *P < 0.05, **P < 0.01, ***P < 0.001, compared with time-matched controls. Scale bars = 40 μm. (Fig. 5) . 
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To investigate the effect of NaIO 3 on the proliferation of L2.3 cells, we measured the incorporation of BrdU. The ratio of BrdU-positive cells peaked on day 2. There was no significant difference in BrdU incorporation ratio between treated and control groups on day 1. On days 2 and 3, the BrdU incorporation ratio of RGCs treated with medium and high doses of NaIO 3 was lower than those of control cells and those treated with low doses of NaIO 3 . However, there was no significant difference in the ratio between the low-dose NaIO 3 group and controls (Fig. 6 ).
NaIO3-induced inhibition of the Wnt/β-catenin signaling cascade
AXIN2 is a direct target of Wnt, and Axin2 expression is used to evaluate Wnt/β-catenin signaling [36] . In contrast, Wnt signaling inhibits GSK-3β activity [37] . To evaluate the role of the Wnt/β-catenin signaling pathway in NaIO 3 -treated L2.3 cells, we performed real-time PCR assays to evaluate the expression levels of Axin2, β-catenin and Gsk-3β. Treatment with NaIO 3 inhibited the expression of Axin2 and β-catenin mRNAs, whereas the expression of Gsk-3β (Fig. 7A-C) significantly increased.
To confirm the role of the Wnt/β-catenin pathway in the apoptosis and proliferation of L2.3 cells exposed to NaIO 3 , we treated the cultures with the Wnt agonist CHIR99021. The decrease in density of RGCs induced by medium and high doses of NaIO 3 was blocked A Representative cell-cycle data. B Statistical analysis. All data are expressed as the mean ± SD of at least three separate experiments. *P < 0.05, **P < 0.01, ***P < 0.001, versus untreated cells.
Effect of NaIO 3 on the potential of L2.3 cells to differentiate
Tuj1 and GFAP are markers for newly generated neurons and astrocytes, respectively [38] . In the presence of increasing concentrations of NaIO 3 , the ratio of Tuj1-positive cells decreased (Fig. 8A-D) and the expression differences were statistically significant according Data from at least three independent experiments are expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, versus untreated cells. Scale bars = 20 μm. Fig. 9 . Analysis of GFAP e x p r e s s i o n on day 7 after treatment with NaIO 3 . A-E Representative confocal images of GFAP immunofluorescence. Cell nuclei were labeled with DAPI. Scale bars = 20 μm. The data represent the mean ± SD of three independent determinations. *P < 0.05, **P < 0.01, ***P < 0.001, versus untreated cells. Data from at least three independent experiments are expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, versus untreated cells. Scale bars = 20 μm. C-E Quantification of the relative levels of transcription of genes encoding components of the TGF-β1/SMAD2/3 signaling pathway. All data are expressed as the mean ± SD from at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, versus untreated cells. F). Moreover, the results of the FACS analysis support the conclusion that NaIO 3 inhibited neuronal differentiation, which is consistent with the immunocytochemical results ( Fig.  10A-E) .
We next determined the expression of GFAP and found no significant difference between the cells treated with different concentrations of NaIO 3 and the controls (Fig. 9) . When we determined the levels of GFAP expression using FACS, the results were the opposite of those for Tuj1 expression described above and indicated that more L2.3 cells differentiated into astrocytes in the presence of increasing concentrations of NaIO 3 ( Fig. 10F-J) .
To exclude the influence of cell death, we analyzed the differentiation of RGCs with birthdating by adding BrdU to the differentiation medium on day 0. On day 7, the ratio of Tuj1/BrdU double-stained cells in BrdU-positive cells decreased as a function of NaIO 3 concentration, while there was no significant difference in the ratio of GFAP/BrdU doublestained cells among the BrdU-positive cells treated with different doses of NaIO 3 . These results are consistent with those acquired using immunocytochemical analyses (Fig. 11) . To further analyze the effect of NaIO 3 on the differentiation potential of L2.3 cells, we analyzed the levels of mRNAs encoding Noggin, BMP4, TGF-β1, SMAD2, and SMAD3, which are critical components of the Noggin and TGF-β1/SMAD2/3 signaling pathways. NaIO 3 treatment at all concentrations did not alter the level of Nog expression on the first and third days after differentiation; however, on the seventh day, Nog expression was markedly downregulated in cells treated with NaIO 3 , compared with the expression in the control (Fig. 12A) . The expression level of Bmp4 did not differ significantly among treated cells and controls on day 1. In contrast to the findings for Nog expression, Bmp4 expression began to increase from day 3 and became significantly higher by day 7 (Fig. 12B) . The expression levels of Tgf-β1, Smad2, and Smad3 in treated and untreated cultures started to increase on day 1, reached a peak on the day 3, and decreased slightly on day 7 ( Fig. 12C-E) .
Discussion
Genetic and age-related diseases caused by the degeneration or dysfunction of the RPE represent the most common causes of visual loss and blindness [39, 40] . For over 60 years, researchers focusing on preventing and treating visual impairment have employed the animal model of retinal injury induced by systemic injection with NaIO 3 [41] because it faithfully reflects the pathogenesis of acute retinal damage. Thus, intravenous injection of NaIO 3 leads to selective degeneration and atrophy of the RPE and subsequent injury to photoreceptors. However, the effect of NaIO 3 on endogenous RSCs is still unclear. Therefore, the goal of the present study was to take advantage of the NaIO 3 model system to better understand the potential of RGCs to proliferate and differentiate, with the hope of stimulating more research on degenerative diseases of the eye.
Here, we found that NaIO 3 caused significant damage to L2.3 cells in vitro. Thus, cell density and BrdU incorporation decreased as a function of increase in the NaIO 3 concentration with a concomitant increase in apoptosis. Although cell cycle analysis indicated that the mitotic ratio of cells treated with the highest dose of NaIO 3 was the highest on days 2 and 3 after treatment, a greater number of cells underwent apoptosis, causing an overall marked decrease in cell density. NaIO 3 exposure usually resulted in the degeneration of mouse RPE cells selectively, followed by the apoptosis of photoreceptors in the retina. It demonstrated that the necrosis of RPE cells in the mice was evoked as early as 6 hours post NaIO 3 treatment, while apoptosis of the photoreceptors were observed at 24 hours, peaked on day 3 and completed on days 7 [14, 42] . Our experiment showed that NaIO 3 also induced the apoptosis of L2.3 cells in a dose-dependent manner. NaIO 3 inhibited the proliferation of L2.3 cells, which prompted us to investigate the underlying mechanism. The Wnt/β-catenin signal transduction pathway plays an important role in the proliferation capacity of L2.3 cells. L'Episcopo et al. found that oxidative injury to RGCs leads to downregulation of the expression of β-catenin and the overexpression of GSK-3β, whereas inhibiting Wnt/β-catenin signaling using small interfering RNA to inhibit GSK-3β expression or antagonize GSK-3β activity reverses neurogenic impairment [37, 43] . These findings indicate that the Wnt/β-catenin/GSK-3β pathway acts to regulate the proliferation of injured RGCs. Consistent with these results, we found here that NaIO 3 downregulated the expression of Axin2 and β-catenin and, in contrast, upregulated the expression of Gsk-3β in concert with the decrease in the proliferation of L2.3 cells. Further, a Wnt agonist efficiently reversed the inhibitory effects of NaIO 3 on the proliferation of RGCs. These findings indicate that NaIO 3 impaired the ability of RGCs to proliferate through inhibition of the Wnt/β-catenin pathway.
NSCs differentiate into astrocytes, oligodendrocytes, and neurons [38, 44] . Müller glial cells are considered RGCs in the retina, and their overgrowth may lead to the formation of glial scars in the retina, potentially followed by loss of vision. Therefore, we investigated [29] . The balance between Noggin and BMP4 signaling regulates the differentiation pathway of radial glia. Here, we found that downregulation of Noggin and upregulation of BMP4 occurred almost simultaneously when cells were treated with NaIO 3 . This result is consistent with the inhibition of neuronal differentiation.
TGF-β1 is a pleiotropic cytokine that orchestrates multiple physiological events in the nervous system [45] . The canonical TGF-β1 signaling pathway involves the transcription factors SMAD2/3 and SMAD4. TGF-β1 induces the receptor-mediated phosphorylation of SMAD2/3, which then bind to SMAD4 to promote differentiation to astrocytes in vitro and in vivo [46] . Moreover, TGF-β1 is one of the most important astrocytic factors [32] . Li et al. reported that RGCs differentiate into astrocytes within 6 days in vitro culture in DMEM/F12-containing N2B27 differentiation medium [35] . Here, we found that the expression of Tgf-β1 and Smad2/3 was significantly elevated on day 3 after NaIO 3 exposure and dropped slightly on day 7, suggesting that differentiation into astrocytes peaked on day 3.
In summary, to our knowledge, this study is the first to show that NaIO 3 exerts remarkable effects on the apoptosis, proliferation and the differentiation potential of RGCs in vitro. Moreover, our results suggest that the Wnt/β-catenin, Noggin, and TGF-β1/SMAD2/3 signaling pathways mediate these events. Although further studies are necessary, our findings provide a theoretical basis for innovation and indicate that inhibiting the differentiation of RSCs into astrocytes may offer a new therapeutic strategy for preventing impairment of vision caused by astrocyte-induced retinal scar formation.
